Discrepant NOXA (PMAIP1) transcript and NOXA protein levels: a potential Achilles' heel in mantle cell lymphoma.
about
Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsTargeting the overexpressed ROC1 induces G2 cell cycle arrest and apoptosis in esophageal cancer cellsMLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinomaIGF expression in HPV-related and HPV-unrelated human cancer cells.Regulation of the DNA damage response by ubiquitin conjugation.Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells.Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agentsMethylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenesTargeting PI3-kinase (PI3K), AKT and mTOR axis in lymphoma.Dual targeting of MCL1 and NOXA as effective strategy for treatment of mantle cell lymphoma.Effects of β-estradiol on cold-sensitive receptor channel TRPM8 in ovariectomized rats.Noxa and cancer therapy: Tuning up the mitochondrial death machinery in response to chemotherapy.Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphomaMLN4924 suppresses neddylation and induces cell cycle arrest, senescence, and apoptosis in human osteosarcomaProtein neddylation and its alterations in human cancers for targeted therapy.Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXAPhenotypic miRNA Screen Identifies miR-26b to Promote the Growth and Survival of Endothelial Cells
P2860
Q28075606-8BF65623-6E28-4DA3-8664-666C682F2CC6Q33710037-262D1E20-4630-45BE-B584-A2F0CF723223Q33912016-F29D05DF-2583-4EDA-94EE-ABE9B50331A3Q34000598-E4530361-500B-4E55-9E3D-1C3B58EC2EA7Q35161624-99FF1FEF-9CA0-48CC-BB70-B3C89AFC110CQ36215406-40D2836C-C41F-4DD6-BA60-CEF20DB2E1A0Q36293814-D6269E5C-0EB4-4E28-9604-90D5E25F0378Q37110909-7F835588-2DE2-4A4A-A861-EA27BE023128Q38237619-10554DBC-00F3-41B5-9FDE-CB32085FC15AQ38712214-D209619E-C442-400D-B30C-DC73F6196B23Q38720224-239DDB9C-890F-4A1D-BF0F-179D58205FF7Q38866647-630E783F-014E-4ADF-9D92-4C8CCD4E2046Q39926284-F69097F0-538E-40E8-993E-EC530130A5F8Q40851893-4FAD7581-33D1-4062-B5F5-128B556C43E1Q48538797-147B214D-4367-4A4C-96AE-E7120429329EQ58765200-9BB3990B-3D5C-441E-97FC-75460D6011F3Q58766575-B0758481-E57A-4CCA-8BFB-75D8125A3F67
P2860
Discrepant NOXA (PMAIP1) transcript and NOXA protein levels: a potential Achilles' heel in mantle cell lymphoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Discrepant NOXA (PMAIP1) trans ...... heel in mantle cell lymphoma.
@en
Discrepant NOXA
@nl
type
label
Discrepant NOXA (PMAIP1) trans ...... heel in mantle cell lymphoma.
@en
Discrepant NOXA
@nl
prefLabel
Discrepant NOXA (PMAIP1) trans ...... heel in mantle cell lymphoma.
@en
Discrepant NOXA
@nl
P2093
P2860
P356
P1476
Discrepant NOXA (PMAIP1) trans ...... heel in mantle cell lymphoma.
@en
P2093
A M Staiger
A Weilbacher
H van der Kuip
M A Dengler
M C Vöhringer
M Gutekunst
W E Aulitzky
P2860
P2888
P356
10.1038/CDDIS.2013.552
P577
2014-01-23T00:00:00Z
P5875
P6179
1012544495